As Markets Tanked, Midwest Life-Sci Shops Closed Record VC Financing Deals in Q3 | GenomeWeb
How did a flyover section of the US set record private-equity deals in the face of an overarching national financial crisis that left scores of banks, analysts, and all kinds of investors numb with terror?
 
During the third quarter, as the US credit and equities markets were seizing, life-sciences and other healthcare companies across the Midwest collected record-high levels of venture capital, a new report by the Cleveland business development consultancy BioEnterprise has concluded.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.